CNS & Neurological Disorders - Drug Targets

(Formerly Current Drug Targets - CNS & Neurological Disorders)

Editor-in-Chief:

Cesar V. Borlongan
Department of Neurosurgery and Brain Repair
University of South Florida Morsani College of Medicine
Tampa, FL
USA

Back

Become EABM
Become Reviewer

Editorial [Hot Topic: Neuropeptide Systems as Novel Targets for Psychiatric Disorders (Guest Editor: Guy Griebel) ] promotion: free to download

Volume:5   Issue:2
Pp: 133-133
Guy Griebel
DOI: 10.2174/187152706776359637

Neuropeptides in Psychiatric Diseases: An Overview with a Particular Focus on Depression and Anxiety Disorders

Volume:5   Issue:2
Pp: 135-145
A. Surget, S. Leman, G. Griebel, C. Belzung and I. Yalcin
DOI: 10.2174/187152706776359682

Neuropeptide Y: Role in Emotion and Alcohol Dependence

Volume:5   Issue:2
Pp: 181-195
R. Quirion, Y. Dumont and C. Carvajal
DOI: 10.2174/187152706776359592

Gastrin-Releasing Peptide Receptor as a Molecular Target for Psychiatric and Neurological Disorders

Volume:5   Issue:2
Pp: 197-204
G. Schwartsmann, J. A.P. Henriques and R. Roesler
DOI: 10.2174/187152706776359673

Novel Treatments of Schizophrenia: Targeting the Neurotensin System

Volume:5   Issue:2
Pp: 205-218
B. Kinkead and C. B. Nemeroff
DOI: 10.2174/187152706776359655

Alcoholism and Neuropeptides: An Update

Volume:5   Issue:2
Pp: 233-239
M. S. Cowen and A. J. Lawrence
DOI: 10.2174/187152706776359646